Advertisement

Drugs & Therapy Perspectives

, Volume 20, Issue 3, pp 21–22 | Cite as

First reports of adverse drug reactions (ADRs) in recent weeks

Drug Reactions and Interactions
  • 25 Downloads

Keywords

Adis International Limited Drug Reaction Adverse Drug Reaction International Literature Publish Case Report 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Opatrny L, Khwaja K, Kimoff J, et al. Death related to albendazole-induced pancytopenia: case report and literature review [abstract]. 52nd Annual Meeting of the American Society of Tropical Medicine and Hygiene; 2003 Dec 3–7; PhiladelphiaGoogle Scholar
  2. Lo SH-K, Wong K-S, Mo K-L. Treatment by haemodialysis in a case of adult-onset (type II) citrullinaemia in a Chinese patient with pulmonary tuberculosis. Nephrol Dial Transplant 2003 Oct; 18 (10): 2182–4.PubMedCrossRefGoogle Scholar
  3. Gaku S, Naoshi K, Teruhiko A. A case of bepridil induced interstitial pneumonitis. Heart 2003 Dec; 89 (12): 1415PubMedCrossRefGoogle Scholar
  4. Sodhi PK, Verma L, Ratan J. Dermatological side effects of brimonidine: a report of three cases. J Dermatol 2003 Sep; 30 (9): 697–700.PubMedGoogle Scholar
  5. Polard E, Trioux E, Flet L, et al. Luclopathy induced by levodopa associated with bromocriptin. Presse Med 2003 Aug 9; 32 (26): 1223.PubMedGoogle Scholar
  6. Ugland HG, Myhr K, Brørs O, et al. Brain stem infarction associated with bupropion. Pharmacoepidemiol Drug Saf 2003 Oct; 12 Suppl. 2: 269Google Scholar
  7. Morton A, Muir J, Lim D. Rash and acute nephritic syndrome due to candesartan. BMJ 2004 Jan 3; 328 (7430): 25.PubMedCrossRefGoogle Scholar
  8. Srairi S, El Aïdli S, Kastalli S, et al. Fixed drug eruption induced by carbocisteine. Pharmacoepidemiol Drug Saf 2003 Oct; 12 Suppl. 2: 265Google Scholar
  9. Finsterer J, Kotzailias N. Thrombocytosis under ciprofloxacin and tazobactam/piperacillin. Platelets 2003 Aug; 14 (5): 329–31.PubMedCrossRefGoogle Scholar
  10. Richards S, Umbreit JN, Fanucchi MP, et al. Selective serotonin reuptake inhibitor-induced rhabdomyolysis associated with irinotecan. South Med J 2003 Oct; 96 (10): 1031–3.PubMedCrossRefGoogle Scholar
  11. Adson DE, Kotlyar M. Premature ejaculation associated with citalopram withdrawal. Ann Pharmacother 2003 Dec; 37 (12): 1804–6.PubMedCrossRefGoogle Scholar
  12. Phillips EJ, Knowles SR, Shear NH. Serum sickness-like reaction associated with clopidogrel. Br J Clin Pharmacol 2003 Nov; 56 (5): 583PubMedCrossRefGoogle Scholar
  13. Tröger U, Lins H, Banditt P, et al. Tetraparesis in a patient with colchicine retention in the cerebrospinal fluid due to verapamil probably by inhibition of PGP efflux pump. Int J Clin Pharmacol Ther 2003 Nov; 41 (11): 555–6.Google Scholar
  14. De Angelis R, Silveri F, Bugatti L, et al. Raynaud’s phenomenon after combined adjuvant chemotherapy for breast cancer. Chemotherapy 2003 Sep; 49 (5): 267–8.PubMedCrossRefGoogle Scholar
  15. Onofrj M, Thomas A. Severe worsening of parkinsonism in Lewy body dementia due to donepezil. Neurology 2003 Nov 25; 61 (10): 1452.PubMedCrossRefGoogle Scholar
  16. Mangge H, Gindl S, Kenzian H, et al. Atopic dermatitis as a side effect of anti-tumor necrosis factor-alpha therapy. J Rheumatol 2003 Nov; 30 (11): 2506–7.PubMedGoogle Scholar
  17. Schöttker B, Dösch A, Kraemer DM. Severe hepatotoxicity after application of desloratadine and fluconazole. Acta Haematol 2003; 110 (1): 43–4.PubMedCrossRefGoogle Scholar
  18. Katz HT, Lang DM, Inamdar SR, et al. Successful desensitization to glatiramer acetate (Copaxone) in two patients with multiple sclerosis [abstract no. P156 plus poster]. Annual Meeting of the American College of Allergy, Asthma and Immunology; 2003 Nov 7–12; New Orleans, 62–63Google Scholar
  19. Uchida H, Suzuki T, Watanabe K, et al. Antipsychotic-induced paroxysmal perceptual alteration. Am J Psychiatry 2003 Dec; 160 (12): 2243–4.PubMedCrossRefGoogle Scholar
  20. Otte W, Birkenhager TK, van den Broek WW. Fatal interaction between tranylcypromine and imipramine. Eur Psychiatry 2003 Aug; 18 (5): 264–5.PubMedCrossRefGoogle Scholar
  21. Mabudian M, Kumar P. Unusual adverse reaction of intravenous immunoglobulin (IVIG) in patient with idiopathic thrombocytopenic purpura (ITP) [abstract no. P166 plus poster]. Annual Meeting of the American College of Allergy, Asthma and Immunology; 2003 Nov7–12; New Orleans, 65Google Scholar
  22. Eklund KK, Peltomaa R, Leirisalo-Repo M. Occurrence of pulmonary thromboembolism during infliximab therapy. Clin Exp Rheumatol 2003 Sep–Oct; 21 (5): 679PubMedGoogle Scholar
  23. Tan E-K, Chan L-L, Lo Y-L. Myorhythmia slow facial tremor from chronic interferon alpha-2a usage. Neurology 2003 Nov; 61 (9): 1302–3.PubMedCrossRefGoogle Scholar
  24. Martínez-Alonso JC, Domínguez-Ortega FJ, Fuentes-Gonzalo MJ. Urticaria and angioedema due to itraconazole. Allergy 2003 Dec; 58 (12): 1317–8.PubMedCrossRefGoogle Scholar
  25. Kazama JJ, Suzuki K, Yokoseki A, et al. Development of hungry bone syndrome after rapid lowering of PTH with intravenous maxacalcitol therapy in a patients with non-uremic secondary hyperparathyroidism. Clin Nephrol 2003 Nov; 60 (5): 369–71.PubMedGoogle Scholar
  26. Margolin L. Impaired rehabilitation secondary to muscle weakness induced by meropenem. Clin Drug Invest 2003; 24 (1): 61–2.CrossRefGoogle Scholar
  27. Fogl T, Margolese HC. Fungal dermatitis with olanzapine in schizophrenia. Can J Psychiatry 2003 Oct; 48 (9): 643–4.PubMedGoogle Scholar
  28. Duijvestijn YCM, Kalmeijer MD, Passier ALM, et al. Neonatal intraventricular haemorrhage associated with maternal use of paroxetine. Br J Clin Pharmacol 2003 Nov; 56 (5): 581–2.PubMedCrossRefGoogle Scholar
  29. Kontaxakis VP, Havaki-Kontaxaki BJ, Pappa DA, et al. Neuroleptic malignant syndrome after addition of paroxetine to olanzapine. J Clin Psychopharmacol 2003 Dec; 23 (6): 671–2.PubMedCrossRefGoogle Scholar
  30. Cohen MA, Galbut B, Kerdel FA. Exogenous lipoid pneumonia caused by facial application of petrolatum. J Am Acad Dermatol 2003 Dec; 49 (6): 1128–30.PubMedCrossRefGoogle Scholar
  31. Bahrainwala AH. Eczema herpeticum during treatment of atopic dermatitis with pimecrolimus (Eledil, 1%) cream [abstract]. Annual Meeting of the American College of Allergy, Asthma and Immunology; 2003 Nov 7–12; New Orleans, 54Google Scholar
  32. Löbbe J, Stucky L, Saurat JH. Rosaceiform dermatitis with follicular Demodex after treatment of facial atopic dermatitis with 1% pimecrolimus cream. Dermatology 2003; 207 (2): 205–7.CrossRefGoogle Scholar
  33. Ratinahirana H, Benigni J-P, Bousser M-G. Injection of polidocanol foam (PF) in varicose veins as a trigger for attacks of migraine with visual aura. Cephalalgia 2003 Oct; 23 (8): 850–1.PubMedCrossRefGoogle Scholar
  34. Anagnostopoulos GK, Kostopoulos P, Tsiakos S, et al. Fulminant pancreatitis associated with ramipril therapy. Pancreas 2003 Oct; 27 (3): 278–9.PubMedCrossRefGoogle Scholar
  35. Goyal RS, Goyal SB. Symptomatic bradyarrhythmia secondary to risperidone. Am J Psychiatry 2003; 160 (12): 2243.PubMedCrossRefGoogle Scholar
  36. Hellerstedt B, Ahmed A. Delayed-type hypersensitivity reaction or serum sickness after rituximab treatment. Ann Oncol 2003 Dec; 14 (12): 1792PubMedCrossRefGoogle Scholar
  37. King DS, Wilburn AJ, Wofford MR, et al. Cognitive impairment associated with atorvastatin and simvastatin. Pharmacotherapy 2003 Dec; 23 (12): 1663–7.PubMedCrossRefGoogle Scholar
  38. Shah P, Ramesh S. Desensitization of a patient with growth hormone hypersensitivity [abstract no. P155 plus poster]. Annual Meeting of the American College of Allergy, Asthma and Immunology; 2003 Nov 7–12; New Orleans, 62Google Scholar
  39. Kuczkowski KM, Benumof JL. Rebound hyperkalemia after cessation of intravenous tocolytic therapy with terbutaline in the treatment of preterm labor: anesthetic implications. J Clin Anesth 2003; 15 (5): 357–8.PubMedCrossRefGoogle Scholar
  40. Umebayashi Y, Furuta J. Anaphylaxis due to tosufloxacin tosilate. J Dermatol 2003 Sep; 30 (9): 701–2PubMedGoogle Scholar
  41. Belahcen A, Erreimi N, Benkirane R, et al. Secondary hyperparathyroidism caused by valproic acid and phenobarbital: a case report. Pharmacoepidemiol Drug Saf 2003 Oct; 12 Suppl. 2: 207–8Google Scholar
  42. Kastalli K, El A¿dli S, Daghfous R, et al. Nightmares induced by valsartan. Pharmacoepidemiol Drug Saf 2003 Oct; 12 Suppl. 2: 236Google Scholar
  43. Ladas ID, Moschos MM, Rouvas AA, et al. Lacquer crack formation after photodynamic therapy. Eur J Ophthalmol 2003 Oct; 13 (8): 729–33.PubMedGoogle Scholar
  44. Suvarna R, Pirmohamed M, Henderson L. Possible interaction between warfarin and cranberry juice. BMJ 2003 Dec 20; 327 (7429): 1454.PubMedCrossRefGoogle Scholar
  45. Privitera MR, Maharaj K. Mania from dose-related ziprasidone augmentation of an SSRI. J Clin Psychiatry 2003 Nov; 64 (11): 1393–4.PubMedCrossRefGoogle Scholar
  46. Licina M, Tavcar R. Facialis palsy attributable to depot antipsychotic therapy. Can J Psychiatry 2003 Nov; 48 (10): 712–3.PubMedGoogle Scholar

Copyright information

© Adis Data Information BV 2004

Personalised recommendations